Compared with “Yinzhihuang” injection, CSBI has a better effect on patients with acute and chronic viral hepatitis and significantly decreased the levels of ALT, AST, and TBIL [94]; the degrees of reduction in TBIL, DBIL, and ALT were also significantly different [95]. This evidence concerns the gene GPT and animal viral hepatitis.